Login / Signup

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.

Bianca Maria PiracciniUlrike Blume-PeytaviF ScarciJ M JansatM FalquésR OteroM L TamaritJ GalvánV TebbsE Massananull null
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Topical finasteride significantly improves hair count compared to placebo and is well tolerated. Its effect is similar to that of oral finasteride, but with markedly lower systemic exposure and less impact on serum DHT concentrations.
Keyphrases
  • phase iii
  • benign prostatic hyperplasia
  • open label
  • clinical trial
  • double blind
  • placebo controlled
  • phase ii
  • wound healing
  • peripheral blood
  • platelet rich plasma